Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H12FN5O |
Molecular Weight | 309.2978 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]1(NC(=O)C2=CC(=CC=C12)C3=CNN=C3)C4=NC=NC=C4F
InChI
InChIKey=KNLVLWZENYQYRT-MRXNPFEDSA-N
InChI=1S/C16H12FN5O/c1-16(14-13(17)7-18-8-19-14)12-3-2-9(10-5-20-21-6-10)4-11(12)15(23)22-16/h2-8H,1H3,(H,20,21)(H,22,23)/t16-/m1/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P50613 Gene ID: 1022.0 Gene Symbol: CDK7 Target Organism: Homo sapiens (Human) Sources: https://patents.google.com/patent/WO2014143601A1/en |
3.3 nM [IC50] |
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
81689696
Created by
admin on Sat Dec 16 20:10:15 GMT 2023 , Edited by admin on Sat Dec 16 20:10:15 GMT 2023
|
PRIMARY | |||
|
1627696-51-8
Created by
admin on Sat Dec 16 20:10:15 GMT 2023 , Edited by admin on Sat Dec 16 20:10:15 GMT 2023
|
PRIMARY | |||
|
PZU987ZDK2
Created by
admin on Sat Dec 16 20:10:15 GMT 2023 , Edited by admin on Sat Dec 16 20:10:15 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)